OEGNX | TRQZX | OEGNX / TRQZX | |
Total Expense Ratio | 1.30 | 0.00 | - |
Annual Report Gross Expense Ratio | 1.30 | 0.61 | 213% |
Fund Existence | 25 years | 6 years | - |
Gain YTD | 7.001 | 3.644 | 192% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.39B | 26.8B | 24% |
Annual Yield % from dividends | 0.00 | 0.60 | - |
Returns for 1 year | 3.85 | -4.55 | -85% |
Returns for 3 years | 44.32 | 25.69 | 173% |
Returns for 5 years | 1.81 | -1.13 | -160% |
Returns for 10 years | 60.15 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MART | 37.29 | -0.50 | -1.33% |
AllianzIM U.S. Large Cp Buffer10 Mar ETF | |||
IHE | 74.04 | -1.54 | -2.04% |
iShares US Pharmaceuticals ETF | |||
GLOF | 50.37 | -1.33 | -2.57% |
iShares Global Equity Factor ETF | |||
CGGO | 33.63 | -0.92 | -2.66% |
Capital Group Global Growth Equity ETF | |||
FETH | 39.88 | -3.42 | -7.90% |
Fidelity Ethereum Fund |